Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Overview of the Vascular System

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...

Hemorrhagic Stroke ll: Pathophysiology

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

Hemorrhagic Stroke l: Introduction

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Response to teprotumumab in thyroid eye disease patients of long duration and high clinical activity score.

Orbit (Amsterdam, Netherlands)·2026

Same author

Histiocytic Sarcoma of the Eyelid: An Uncommon Presentation of a Rare Neoplasm.

Ophthalmic plastic and reconstructive surgery·2026

Same author

Severe Congenital Ptosis Repair: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026

Same author

The Role of Corticosteroids in the Management of Orbital Cellulitis: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026

Same author

Spontaneous regression of a presumed orbitocranial eosinophilic granuloma in an adult patient: illustrative case.

Journal of neurosurgery. Case lessons·2026

Same author

Extended Long-Term Follow-Up of Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease.

Ophthalmic plastic and reconstructive surgery·2026

Search research articles

Related Experiment Video

Updated: May 8, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

Infantile hemangiomas: A review.

Alison B Callahan¹, Michael K Yoon

¹Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society

|August 21, 2013

Summary

This summary is machine-generated.

Infantile hemangiomas (IH), common childhood eyelid tumors, can cause vision problems and disfigurement. This review covers current understanding, management, and emerging therapies for these benign lesions.

Keywords:

Capillary hemangioma Infantile hemangioma Propranolol treatment

More Related Videos

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

Related Experiment Videos

Last Updated: May 8, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay

Published on: April 12, 2018

Area of Science:

Ophthalmology
Pediatric Oncology
Dermatology

Background:

Infantile hemangiomas (IH) are the most frequent eyelid and orbital tumors in children.
While typically benign and self-limiting, periocular IH can lead to amblyopia, strabismus, and significant cosmetic concerns.
Treatment decisions for IH can cause considerable anxiety for all involved.

Purpose of the Study:

To review the current understanding of infantile hemangiomas in the periocular region.
To discuss established and emerging management strategies for infantile hemangiomas.
To explore future therapeutic directions for infantile hemangiomas.

Main Methods:

Literature review of infantile hemangiomas (IH).
Analysis of current treatment modalities for periocular IH.
Discussion of emerging therapies and future research directions.

Main Results:

Infantile hemangiomas present unique challenges in the periocular region.
Various treatment options exist, with emerging therapies offering improved safety and efficacy.
A comprehensive understanding of IH management is crucial for optimal outcomes.

Conclusions:

Effective management of infantile hemangiomas requires a multidisciplinary approach.
Emerging therapies hold promise for safer and more effective treatment of periocular IH.
Continued research is essential to advance the care of children with infantile hemangiomas.